"I Honestly Cannot Remember What Was Injected"

"I had something injected five years ago at a clinic overseas — they closed, and I have no records." At FILLER REVISION, this is one of the most common opening statements we hear. Patients present with lumps, contour distortions, or recurring swelling, but they have no idea what material is causing the problem. Some had injections at clinics that no longer exist, some received treatments in other countries, and some were simply never told what was used.

At FILLER REVISION, we consider unknown material identity the single greatest obstacle in filler complication management. Different materials require fundamentally different treatment strategies — HA can be attempted with dissolving enzymes, but Radiesse, Sculptra, Ellanse, and silicone cannot. Treating without knowing the material is equivalent to operating blindfolded.

Why Material Identification Is So Critical

Material | Dissolvability | Correct Approach | Risk of Wrong Approach

---------- | --------------- | ----------------- | ----------------------

Hyaluronic acid (HA) | Hyaluronidase available | Dissolving enzyme or extraction | If encapsulated, dissolvers fail

Calcium hydroxylapatite (CaHA) | Cannot be dissolved | Physical extraction | Blind dissolving wastes resources and damages tissue

Poly-L-lactic acid (PLLA) | Cannot be dissolved | Physical extraction | Steroids/5-FU provide only partial improvement

Polycaprolactone (PCL) | Cannot be dissolved | Physical extraction | Extremely long wait for absorption

Silicone | Permanent | Physical extraction | No medication is effective

Unknown injectables | Unknown | Must identify first | Any blind treatment carries risk

Key Insight: At FILLER REVISION, we follow one unbreakable rule: the first step in treating filler complications is not "what method should we use" but "what was actually injected." Material determines strategy, and strategy determines outcome. Skipping material identification and proceeding to treatment is where all errors begin.

How Ultrasound Identifies Different Materials

High-resolution ultrasound works by exploiting the fact that tissues of different densities produce different sound wave reflections (echoes). Each filler material, due to its unique physical and chemical properties, presents distinctive characteristics on ultrasound imaging.

Ultrasound Imaging Characteristics of Various Materials

• Typically appears as hypoechoic (dark) masses

• Relatively well-defined borders

• High water content creates clear contrast with surrounding tissue

• May develop irregular margins over time (after partial absorption)

• Appears as hyperechoic (bright white) punctate deposits or masses

• Very strong echoes due to calcium content

• May produce posterior acoustic shadowing

• Easily distinguished from other materials

• Less pronounced echo characteristics

• May present as scattered tiny hyperechoic points

• Hypoechoic halo from surrounding granulomatous reaction

• Relatively more difficult to identify

• Medium echogenicity masses

• PCL microspheres may appear as punctate hyperechoic foci

• After CMC carrier absorption, primarily microsphere distribution visible

• Distinct fibrous wall visible after encapsulation

• Characteristic "snowstorm" echo pattern

• Hyperechoic with posterior acoustic shadowing

• Borders typically irregular and blurred

• Intermingled with surrounding tissue; clear identification requires experience

Identification Accuracy

Material | Ultrasound Identification Accuracy | Difficulty Level

---------- | ----------------------------------- | -----------------

Radiesse (CaHA) | Very high (>95%) | Easy—strong echo signature

Silicone | High (>90%) | Moderate—snowstorm pattern recognition

Hyaluronic acid | High (>85%) | Moderate—hypoechoic but must exclude others

Ellanse (PCL) | Moderately high (>80%) | Moderate—based on PCL microsphere features

Sculptra (PLLA) | Moderate (>70%) | More difficult—less distinctive features

Mixed Materials: The Most Complex Scenario

Some patients have received multiple injections of different materials in the same area over time. Ultrasound's advantage in these situations is its ability to simultaneously display different echo characteristics at different tissue depths, helping the practitioner understand the complete picture of what is present.

Common mixed scenarios:

• HA followed by Radiesse augmentation

• Multiple brands of HA over time

• Old silicone injections with newer filler layered on top

• Sculptra with subsequent HA touch-ups

The FILLER REVISION Approach: From Identification to Treatment Plan in One Session

At FILLER REVISION, material identification is not a standalone service — it is the first step of a complete treatment workflow performed in a single consultation. Our high-resolution ultrasound identifies the material, maps its distribution and depth, assesses encapsulation status, and evaluates surrounding structures — all in real time. This means that by the end of your first visit, you know what is in your face, where it is, and what treatment options are available. For patients who have spent months being treated with the wrong approach because nobody identified the material first, this single session often provides more clarity than all their previous consultations combined. We have identified silicone in patients who believed they had HA, Radiesse in patients who were told "it will dissolve eventually," and mixed materials that explained why partial treatments kept failing.

Supplementary Information Beyond Ultrasound

While ultrasound is the primary tool for material identification, the following information also helps narrow the possibilities:

• Injection timeline: Earlier injections are more likely to be silicone or other permanent materials

• Injection location: Certain countries or regions had specific material trends during different periods

• Injection site: Certain materials have more common use sites

• Palpation characteristics: Different materials have distinct firmness and texture

• Previous treatment response: Response or non-response to hyaluronidase can confirm or exclude HA

Next Steps After Identification

Material identification is not the endpoint—it is the starting point for correct treatment. After confirming the material, the following must be assessed:

• Precise filler location and depth

• Degree of encapsulation

• Relationship to surrounding structures (vessels, nerves)

• Optimal extraction pathway

Together, this information creates a comprehensive treatment map that guides the subsequent minimally invasive extraction procedure.

Key Insight: The value of ultrasound material identification lies not only in knowing what is there, but in knowing how to manage it. Extraction strategies, instrument selection, and expected outcomes differ by material. Precise material identification transforms treatment from guesswork into planning.

If You Are Unsure What Was Injected

If any of the following applies, we recommend an ultrasound evaluation as soon as possible:

• Injections performed years ago with no memory of the material

• Procedures performed at overseas clinics with no retrievable records

• Original treating clinic has closed

• Suspicion of unapproved materials

• Unexplained lumps or facial contour changes

For the complete evaluation process, see: Filler Repair Evaluation Process. For more on extraction techniques: Filler Lump Extraction Technique Explained.

Conclusion

If you do not know what was injected and previous treatments have failed or been refused because of this uncertainty, FILLER REVISION can provide the answers. Our specialized ultrasound identifies the material, maps its location, and guides the correct treatment strategy — turning an unknown problem into a solvable one.

Stop guessing what is in your face. Book a consultation →